Baird Financial Group
FLNA

Baird Financial Group’s Filana Therapeutics FLNA Stock Holding History

Baird Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,550
Closed -$281K – 1801
2024
Q3 		$281K Buy
+9,550
New +$220K ﹤0.01% 1563
2023
Q3 		– Sell
-14,020
Closed -$344K – 1753
2023
Q2 		$344K Sell
14,020
-2,979
-18% -$71.7K ﹤0.01% 1466
2023
Q1 		$410K Buy
16,999
+4,603
+37% +$128K ﹤0.01% 1389
2022
Q4 		$366K Sell
12,396
-257
-2% -$9.24K ﹤0.01% 1395
2022
Q3 		$529K Sell
12,653
-1,026
-8% -$27.7K ﹤0.01% 1266
2022
Q2 		$385K Sell
13,679
-366
-3% -$9.24K ﹤0.01% 1445
2022
Q1 		$522K Sell
14,045
-27,524
-66% -$1.17M ﹤0.01% 1385
2021
Q4 		$1.82M Sell
41,569
-364
-0.9% -$19.1K ﹤0.01% 975
2021
Q3 		$2.6M Buy
41,933
+3,638
+9% +$304K 0.01% 834
2021
Q2 		$3.27M Sell
38,295
-10,584
-22% -$567K 0.01% 737
2021
Q1 		$2.2M Buy
+48,879
New +$1.92M 0.01% 849

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Baird Financial Group's FLNA Position: Q4 2024 in Review

Baird Financial Group sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 9,550 shares — an estimated $281K sold.

Baird Financial Group first reported a position in FLNA in Q1 2021 and held it in 11 quarters. The position peaked at $3.27M in Q2 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Baird Financial Group reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 9,550 Filana Therapeutics shares in Q4 2024, an estimated $281K.
  • Baird Financial Group first reported a position in Filana Therapeutics in Q1 2021 and held it in 11 quarters.
  • Baird Financial Group's Filana Therapeutics position peaked at $3.27M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.